These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus. Volkow P, Rubí S, Lizano M, Carrillo A, Vilar-Compte D, García-Carrancá A, Sotelo R, García B, Sierra-Madero J, Mohar A. Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958 [Abstract] [Full Text] [Related]
23. Association of HIV Infection With Anal and Penile Low-Risk Human Papillomavirus Infections Among Men Who Have Sex With Men in Amsterdam: The HIV & HPV in MSM Study. Welling CA, Mooij SH, van der Sande MA, van Rooijen MS, Vermeulen-Oost WF, King AJ, van Eeden A, Heideman DA, Stolte IG, Schim van der Loeff MF. Sex Transm Dis; 2015 Jun; 42(6):297-304. PubMed ID: 25970305 [Abstract] [Full Text] [Related]
26. Genital Human Papillomavirus Infection in Indian HIV-Seropositive Men Who Have Sex With Men. Raghavendran A, Hernandez AL, Lensing S, Gnanamony M, Karthik R, Sivasubramanian M, Kannangai R, Abraham P, Mathai D, Palefsky JM. Sex Transm Dis; 2017 Mar; 44(3):173-180. PubMed ID: 28178116 [Abstract] [Full Text] [Related]
27. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Greenblatt RM. J Infect Dis; 2001 Feb 01; 183(3):383-91. PubMed ID: 11133369 [Abstract] [Full Text] [Related]
28. High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. Höpfl R, Petter A, Thaler P, Sarcletti M, Widschwendter A, Zangerle R. BMC Infect Dis; 2003 Apr 30; 3():6. PubMed ID: 12723991 [Abstract] [Full Text] [Related]
31. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Obstet Gynecol; 1994 Feb 30; 83(2):205-11. PubMed ID: 8290181 [Abstract] [Full Text] [Related]
32. Prevalence of human papillomavirus genotypes in women from three clinical settings. Chaturvedi AK, Dumestre J, Gaffga AM, Mire KM, Clark RA, Braly PS, Dunlap K, Beckel TE, Hammons AF, Kissinger PJ, Hagensee ME. J Med Virol; 2005 Jan 30; 75(1):105-13. PubMed ID: 15543579 [Abstract] [Full Text] [Related]
36. The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions. Giraldo PC, Eleutério J, Cavalcante DI, Gonçalves AK, Romão JA, Eleutério RM. Eur J Obstet Gynecol Reprod Biol; 2008 Mar 30; 137(1):88-91. PubMed ID: 17485158 [Abstract] [Full Text] [Related]
37. Prevalence and Risk of Penile Human Papillomavirus Infection: Evidence From The National Health and Nutrition Examination Survey 2013-2014. Deshmukh AA, Tanner RJ, Luetke MC, Hong YR, Sonawane Deshmukh K, Mainous AG. Clin Infect Dis; 2017 May 15; 64(10):1360-1366. PubMed ID: 28205678 [Abstract] [Full Text] [Related]
38. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women infected with human immunodeficiency virus. Rahman M, Sasagawa T, Yamada R, Kingoro A, Ichimura H, Makinoda S. J Med Virol; 2011 Nov 15; 83(11):1988-96. PubMed ID: 21915875 [Abstract] [Full Text] [Related]